Browsing Tag

Test Discontinuation

Referral/Sendouts

Send Out Referral Testing Update: Phase Two Transition to Quest Diagnostics

Go-Live Date: December 17, 2025

Following Phase One in November, where tests previously referred to ARUP and some Mayo Clinic Lab tests were transitioned to Quest Diagnostics, we are now moving into Phase Two of this important change. Corewell Health Laboratory is continuing its transition to Quest Diagnostics as our primary reference testing partner.

Continue Reading

December 10, 2025 by
Referral/Sendouts, Southeast Michigan, Southwest Michigan, West Michigan

Primary Reference Lab Change to Quest Diagnostics

Effective November 19, 2025

Corewell Health Laboratory is transitioning to Quest Diagnostics as our primary reference testing laboratory. This change means that nearly all referral and send-out tests will now be performed by Quest Diagnostics. A limited number of tests will continue to be sent to other laboratories to ensure we meet the needs of our patients and clinicians.

What You Need to Know:

  • Test Crosswalks: Tests currently performed at ARUP and Mayo Clinic Labs will be matched to comparable tests at Quest Diagnostics.
  • Discontinued Tests: Tests with low utilization or those no longer deemed clinically necessary will be discontinued.
  • New LAB Numbers: All tests will receive new LAB numbers, which must be updated in your EMR compendium if interfaced.
  • Collection Devices: Some tests may require different collection devices.
  • Transition Timeline:
    • November 19, 2025: Focus on tests currently referred to ARUP.
    • December 17, 2025: Focus on tests currently referred to Mayo Clinic Labs.
  • Crosswalk Resources: Crosswalks between current and future test offerings will be provided to help you prepare.
  • Test Directory Access: Please refer to your regional Lab Test Directory for details on specific test changes. ARUP and Mayo Clinic Lab test pages will include links to the corresponding Quest Diagnostic tests.

We understand the significance of these changes and are committed to supporting your practice throughout this transition. Updates and modifications will be communicated promptly.

Contact Information:

  • Corewell Health East Sendouts: 248.551.9045
  • Corewell Health West Referrals: 616.267.2753
  • Or use the Contact Us link above.
October 27, 2025 by
General Information

Test Update: Drug Screening Updates

Effective September 3, 2025, Drug Screen with Alcohol and Drug Screen without Alcohol will be discontinued for inpatient testing. The replacement test would be Drug Screen, Immunoassay, Urine [LAB677] for ED and inpatient.
Drug Screen Toxicology, Immunoassay, Urine [LAB3227] is available for outpatient testing.
For any questions or concerns, please contact your account manager or use the contact us link above.

Test Information

Discontinued Tests:
  • Drug Screen with Alcohol, Immunoassay, Urine [LAB2111694]
  • Drug Screen without Alcohol, Immunoassay, Urine [LAB2111041]
August 28, 2025 by
General Information

Test Update: Vitamin D Testing Via Tandem Mass Spectrometry (LAB1230925)

Corewell Health Laboratories has discontinued routine Vitamin D testing via Tandem Mass Spectrometry (LAB1230925). The new test for diagnosing Vitamin D insufficiency and monitoring therapy is Vitamin D, 25-Hydroxy (LAB1231583), performed daily using an in-house immunoassay method.

Vitamin D screening for deficiency/insufficiency will now be conducted via immunoassay. Current requests for Vitamin D2/D3 by Mass Spectrometry will be sent out.

For any questions or concerns, please contact the Corewell Health West Laboratory.

 

TEST INFORMATION

Discontinue: LAB1230925 25-Hydroxyvitamin D2 and D3, Serum

Replacement: LAB1231583 Vitamin D 25 Hydroxy

June 27, 2025 by